Duplex-guided balloon angioplasty and subintimal dissection of infrapopliteal arteries: Early results with a new approach to avoid radiation exposure and contrast material  by Ascher, Enrico et al.
From the Eastern Vascular Society
Duplex-guided balloon angioplasty and subintimal
dissection of infrapopliteal arteries: Early results
with a new approach to avoid radiation exposure
and contrast material
Enrico Ascher, MD, Natalie A. Marks, MD, RVT, Anil P. Hingorani, MD, Richard W. Schutzer, MD,
and Suresh Nahata, MD, Brooklyn, NY
Objective: Balloon angioplasties of stenotic or occluded infrapopliteal arteries may be helpful in selected high-risk patients
threatened with limb loss. Thus far, these procedures have demanded fluoroscopy and the injection of potentially
nephrotoxic contrast material. Herein, we proposed a new alternative to avoid the harmful effects of radiation exposure
and the risk of acute renal failure.
Methods: Over the last 16 months, 30 patients (57% male) aged 74  9 years (mean  SD) had a total of 52 attempted
balloon angioplasties of the infrapopliteal arteries in 32 limbs under duplex guidance. Indications for the procedure were
critical ischemia in 20 limbs (63%), including rest pain, ischemic ulcers, and gangrene in 4 (13%), 10 (31%), and 6 (19%)
limbs, respectively. Severe disabling claudication was an indication in the remaining 12 limbs (37%). All patients had
concomitantly performed balloon angioplasties of the superficial femoral and popliteal arteries (28 cases) or the popliteal
artery alone (4 cases). Balloon angioplasty of the infrapopliteal arteries was performed as an adjunct to improve runoff.
Hypertension, diabetes, renal insufficiency, smoking, and coronary artery disease were present in 77%, 73%, 50%, 47%,
and 37% of cases, respectively. There were 42 cases (81%) with infrapopliteal arterial stenoses (25 tibioperoneal trunks,
9 peroneal arteries, 4 anterior tibial arteries, and 4 posterior tibial arteries) in 26 limbs. The remaining 10 cases (19%) had
infrapopliteal arterial occlusions (4 tibioperoneal trunks, 5 peroneal arteries, and 1 anterior tibial artery) in 6 limbs. All
these cases were combined with more proximal endovascular procedures (21 femoropopliteal stenoses and 11 femoro-
popliteal occlusions). All patients had preprocedure duplex arterial mapping and ankle/brachial index (ABI) measure-
ment. Local anesthesia with light sedation was used in all cases. The common femoral artery was cannulated under direct
duplex visualization. Still under duplex guidance, a guidewire was directed into the proximal superficial femoral artery
and distally, beyond the infrapopliteal diseased segment. The diseased segment was then balloon-dilated. Balloon
diameter and length were chosen according to the arterial measurements obtained by duplex guidance. Completion
duplex examinations were performed and postprocedure ABIs were obtained in all cases.
Results: Although the overall technical success was 94% (49/52 cases), it was 95% for those with stenoses (40/42 cases)
and 90% for those with occlusions (9/10 cases; P < .5). Intraoperative thrombosis occurred in three infrapopliteal cases
(two tibioperoneal trunks and one peroneal artery) and in one popliteal artery. All four cases were successfully managed
with intra-arterial infusion of thrombolytic agents under duplex guidance. Overall, the preprocedure and postprocedure
ABIs ranged from 0.4 to 0.8 (mean SD, 0.58 0.15) and 0.7 to 1.1 (mean SD, 0.9 0.16), respectively (P< .0001).
Twenty-two (88%) of 25 patients experienced a significant (>0.15) postoperative ABI increase. Overall 30-day survival
and limb salvage rates were 100%.
Conclusions: The proposed technique eliminates the need for radiation exposure and the use of contrast material, and it
seems to be an effective alternative approach for the treatment of infrapopliteal occlusive disease. Additional advantages
include accurate selection of the proper size of balloon and confirmation of the adequacy of the technique by
hemodynamic and imaging parameters. ( J Vasc Surg 2005;42:1114–21.)The evolution of endovascular therapy for infrainguinal
ischemia is similar to the one observed in arterial bypass
surgery. Initially, vascular surgeons were reluctant to ex-
tend bypass outflow sites from the popliteal site to more
distal outflow sites. Forty years after the concept of bypass
surgery was introduced by Kunlin1 in 1949, we showed
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1114that vein grafts inserted into the plantar arteries and other
branches of the tibial arteries could help achieve limb
salvage in a substantial number of patients.2 Although
balloon angioplasties are now considered the standard of
care for iliac artery stenoses, the ones performed in the
infrapopliteal vessels are still not widely accepted by the
vascular community. This controversy stems mostly from
the limited patency rates obtained with this technique,
particularly when compared with those achieved with by-
pass operations.3 However, there are several situations in
which infrapopliteal balloon angioplasties may be of bene-
fit: (1) as an adjunct to improve runoff during balloon
angioplasty or bypass surgery of a more proximal arterial
segment, (2) in patients deemed too sick to undergo sur-
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ble because of a wound infection, and (4) when adequate
segments of autogenous vein are not available for a bypass
operation.4-8 Even more controversial is the topic of sub-
intimal dissection of infrapopliteal arteries, a technique
introduced by Bolia et al9 in 1989. Very few such cases have
been reported thus far in the literature, and long-term
results have not been published.
The purpose of this article is not to discuss the merits of
these techniques but simply to offer another method for
performing balloon angioplasties and subintimal dissec-
tions of infrapopliteal arteries without the use of fluoros-
copy or contrast material. The latter is particularly benefi-
cial for patients with diabetes mellitus and for those with
pre-existing chronic renal failure.10,11 As vascular surgeons
become busier with endovascular procedures, they will be
more exposed to the deleterious effects of radiation. Un-
fortunately, these effects are cumulative and permanent and
may cause a delayed onset of symptoms.12 Recently, we
have shown the feasibility of performing duplex-assisted
carotid artery balloon angioplasty and stenting with limited
amounts of radiation and without any contrast material in
some cases.13 This series comprises 52 infrapopliteal arter-
ies in 30 patients who underwent balloon angioplasty,
subintimal dissection, or both performed solely under du-
plex guidance. In this article, we describe our technique
and analyze the early patency and limb-salvage results
achieved with this new approach.
METHODS
Patients. Over the previous 16 months, we attempted
to treat 32 lower limbs in 30 patients who presented to our
institution with symptomatic multisegmental arterial oc-
clusive disease. There were 17 men and 13 women aged
74  9 years (mean  SD; range, 47-92 years). Concom-
itant risk factors such as hypertension, diabetes, renal insuf-
ficiency (serum creatinine levels 1.5 mg/dL), smoking,
and coronary artery disease were present in 77%, 73%, 50%,
47%, and 37% of patients, respectively. Indications for the
procedure were critical ischemia in 20 limbs (63%), includ-
ing rest pain, ischemic ulcers, and gangrene in 4 (13%), 10
(31%), and 6 (19%) limbs, respectively. Severe disabling
claudication (1 block) was an indication in the remaining
12 limbs (37%). One patient (3%) had a history of dye
allergy. All patients had concomitantly performed balloon
angioplasties of the superficial femoral (SFA) and popliteal
arteries (PAs; 28 cases) or the PA alone (4 cases). All of
these cases were performed under duplex guidance alone,
and six of these patients were described in our other article
in this issue. Balloon angioplasty of the infrapopliteal arter-
ies was performed as an adjunct to improve runoff. Four
patients (13%) had a history of contralateral lower extremity
angioplasty. Three additional patients (10%) had had failed
ipsilateral bypasses (two femoral to dorsalis pedis artery with
vein graft and one femoral artery to PA polytetrafluoroeth-
ylene graft). The choice of procedure was dictated by the
surgeon, who considered the associated cardiovascular risk
factors and the patient’s preference. Clopidogrel and aspi-rin were started 48 hours before the procedure and contin-
ued for the duration of the follow-up period.
Preprocedural evaluation. All patients had preproce-
dure duplex arterial mapping by using the technique previ-
ously described by our group.14 We also measured ankle/
brachial indices (ABIs) when pulses were audible. Forefoot
pulse volume recording (PVR) tracing amplitudes were
registered when ABIs were not available.
Concomitant femoropopliteal angioplasties and TASC
classification. All infrapopliteal angioplasties were com-
bined with more proximal endovascular procedures in the
femoropopliteal arterial segment. Concomitant femoro-
popliteal balloon angioplasties were performed in 21 cases
for arterial stenoses (18 primary stenoses and 3 restenoses)
and in 11 cases for arterial occlusions (10 primary occlu-
sions and 1 reocclusion). There were 19 TASC class C
lesions (59%) and 13 TASC class D lesions (41%) in this
series.15 Isolated popliteal stenoses or occlusions were
found in four cases (13%). Significant stenoses and/or
occlusions in both the SFA and the PA were found in the
remaining 28 cases (87%). Of 28 diseased SFAs, 15 (54%)
involved its origin. In four cases (13%), the SFA stenosis
extended into the common femoral artery (CFA).
Infrapopliteal arterial occlusive disease. A total of
52 infrapopliteal arteries were subjected to balloon angio-
plasties. Overall, there were 2 cases (6%) with 2 patent
(50% stenosis) infrapopliteal arteries and 13 cases (41%)
with 1, and in the remaining 17 cases (53%), all 3 infrap-
opliteal arteries were either occluded or significantly dis-
eased (50% stenosis). Infrapopliteal lesion length aver-
aged 3.5  1.2 cm (range, 1-8 cm). The length of the
ballooned segment was 5.2  2.4 cm (range, 2-11 cm).
Forty-two cases (81%) with arterial stenoses were subjected
to balloon angioplasties (25 tibioperoneal trunks [Fig 1], 9
peroneal arteries, 4 anterior tibial arteries, and 4 posterior
tibial arteries) in 26 limbs. The remaining 10 cases (19%)
had arterial occlusions (4 tibioperoneal trunks, 5 peroneal
arteries, and 1 anterior tibial artery) in 6 limbs. Balloon
angioplasty of a single infrapopliteal artery was attempted in
13 cases (41%), that of 2 arteries was attempted in 18 cases
(56%), and the remaining patient (3%) had an angioplasty
of 3 infrapopliteal arteries. All 19 cases that had more than
1 infrapopliteal artery disease had balloon angioplasty of
the tibioperoneal trunk and of the anterior tibial, posterior
tibial, or peroneal artery in 2, 3, and 13 cases, respectively.
In the remaining case, the tibioperoneal trunk angioplasty
preceded similar treatment for both the anterior tibial and
posterior tibial arteries. These were lesions located in the
proximal one third of the tibial vessels.
Technique. All cases were performed in the operating
room. Local anesthesia (an equal mixture of 1% lidocaine
and 0.5% bupivacaine) with light sedation was used in all
cases. The CFA was cannulated under direct duplex visual-
ization. The ipsilateral CFA was the access of choice in 29
cases (91%), and the contralateral CFA, in the remaining 3
cases. In these cases, the up-and-over iliac cannulation was
performed with fluoroscopy. In all cases, the guidewire was
directed into the proximal SFA, across the PA, and into one
osis (
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directional catheter (5F angle taper Glidecath; Terumo
Medical Corporation, Somerset NJ) was used to selectively
cannulate the tibioperoneal trunk and the diseased tibial
vessels. Balloon diameter and length were chosen accord-
ing to arterial measurements obtained by ultrasonography
(Fig 2). Symmetry balloons (Boston Scientific Corpora-
tion, Natick, Mass) were used for smaller arteries (2 and 3
mm), and Ultrathin balloons Boston Scientific Corpora-
tion, Natick, Mass) were used for larger arteries (4 to 7 mm
in diameter). When Symmetry balloons were used, we had
to exchange the regular 0.035-inch guidewire for a thinner
0.018-inch wire. The diseased segments were then balloon-
dilated starting from themost distal lesion. After removal of
the balloon catheter, completion duplex examinations were
performed by means of B-mode, color (Fig 3), and Doppler
spectrum assessment of the entire femoropopliteal segment
and infrapopliteal arteries. A complete scanning of infrap-
opliteal arterial segments allowed detection of distal
thrombi, emboli, or both. Plaque dissections or recoils that
caused a lumen diameter reduction of 30% or more, a peak
systolic velocity stepup of 2 or more, or both were consid-
ered hemodynamically significant. These residual lesions in
femoropopliteal arterial segments were stented under du-
plex guidance. Stent sizes were chosen according to the
Fig 1. Duplex color image of severe stenduplex measurements of the arterial diameter and lesionlength. We compared the mean PA volume flow (PAVF)
measured before and after balloon angioplasty. Papaverine
hydrochloride (30 mg) was administered through the
sheath after the wire removal, and the maximal PAVF
increase was registered. PAVF measurements were always
taken three consecutive times for every time point. The
PAVF values (mean  SD and ranges) were calculated and
recorded.
Postprocedural noninvasive evaluation and follow-
up. Postprocedure ABIs were obtained when possible, and
forefoot PVR tracing amplitudes were obtained in cases of
nonaudible tibial pulses before hospital discharge. Patients
were advised to come back to the outpatient office for
clinical evaluation, arterial duplex scans, and PVR examina-
tions every 3 months for the first year and every 6 months
thereafter.
Statistical analysis. The Fisher exact test (Instat ver-
sion 3.06 for Microsoft Windows; GraphPad Software, San
Diego, Calif) was used to compare technical success be-
tween stenotic and occlusive arterial lesions. Instat (paired t
test; parametric distribution) was also used to compare
preprocedure, postprocedure, andpapaverine-inducedPAVF,
as well as preangioplasty and postangioplasty ABIs and
forefoot PVR tracings. Arterial patency life tables (Kaplan-
77%) in the proximal tibioperoneal trunk.Meier survival test and log-rank comparison of the survival
he ste
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4.00.
RESULTS
Technical success. Postangioplasty duplex scanning
of the femoropopliteal arterial segment showed significant
residual defects that required stent placement in 16 (50%)
of the 32 cases. All of these abnormalities were in the
femoropopliteal segment. Stenting was deemed appropri-
ate in 8 (38%) of 21 cases of transluminal angioplasty,
whereas it was needed in 8 (73%) of 11 cases of subintimal
dissections (P  .1; not significant). We used a variety of
self-expandable stainless-steel and nitinol stents. Significant
plaque recoil was the reason for stent use in 10 cases (63%),
and arterial dissections were the reason in the remaining 6
cases (37%). Technical adequacy was achieved after place-
ment of a single stent in 13 cases, after placement of 2 stents
in 2 cases, and after placement of 3 stents in the remaining
case. Thirteen stents were deployed in the SFA, and 7 stents
were deployed in the above-the-knee PA.
Immediate technical success was achieved in 49 of 52
treated infrapopliteal arteries, with an overall success rate of
94%. In the remaining three cases, the wire would not
traverse a stenotic lesion (two peroneal arteries) or failed to
re-enter during a subintimal dissection (one peroneal ar-
tery). No statistically significant difference was found be-
tween the technical success rate for those with stenoses
Fig 2. Ultrathin balloon (4 mm) fully inflated across t(95%) as compared with those with occlusions (90%; P .5; not significant). Residual defects after angioplasty were
documented in 8 (16%) of the 49 successfully cannulated
infrapopliteal arteries. However, none of these cases was
hemodynamically significant by duplex criteria. Of these,
six (12%) had some plaque recoil (two posterior tibial, two
peroneal, one anterior tibial, and one tibioperoneal trunk),
and two (4%) had arterial dissections (tibioperoneal trunk).
Procedure duration. Duplex-guided balloon angio-
plasty duration ranged from 24 to 180 minutes (mean 
SD, 79  31 minutes; median, 78 minutes).
Intraoperative complications. Intraoperative throm-
bosis occurred in four cases. Two of these occurred in the
tibioperoneal trunk, one in the peroneal artery, and one in
the PA. All three infrapopliteal cases were successfully man-
aged with intra-arterial infusion of thrombolytic agents via
an infusion catheter positioned within the thrombus under
duplex guidance. For thrombolytic therapy, we used 2 to 4
mg of tissue plasminogen activator mixed with 10 to 20mL
of normal saline. This solution was pulse-sprayed. Approx-
imately 10 minutes later, the duplex examination was re-
peated. Complete clot lysis was achieved in all three cases
during the primary procedure. The remaining PA case was
treated successfully under duplex guidance with the help of
a suction thrombectomy device. Because intraoperative
thrombosis of the outflow vessel was resolved during the
same intervention, it was still counted as a technical success.
Postoperative complications. One patient who had
notic lesion in the tibioperoneal trunk shown in Fig 1.an intraoperative tibioperoneal trunk thrombosis and
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fasciotomy. The wounds healed well, and he was dis-
charged without sequelae.
Although we did not use arterial closure devices in this
series, there were no local puncture complications. All
patients left the operating room with a short sheath (6F). It
was removed in the recovery room after normalization of
the activated clotting time (150 seconds) within 60 to
120 minutes after the procedure, and manual or C-clamp
pressure was applied for another 20 to 30 minutes.
Popliteal artery volume flow. The mean PAVF in-
creased from a preprocedural value of 51  24 mL/min
(range, 10-94 mL/min) to a postprocedural value of 154 
57 mL/min (range, 30-315 mL/min). This difference was
statistically significant (P  .0001). Mean PAVF increased
to 311  100 mL/min (range, 105-480 mL/min) after
papaverine administration.
Postoperative ABIs. ABIs were reliably obtained in
25 cases (78%). In the remaining seven cases, accurate ankle
pressure measurements were not possible because of either
incompressible calcified arteries (one case) or nonaudible pulses
(six cases). The preoperative ABIs in the 25 cases ranged
from 0.3 to 0.89, with a mean of 0.59 0.16, whereas they
ranged from 0.68 to 1.1, with a mean of 0.88 0.12, after
Fig 3. Completion color image of the same tibioperone
the artery is widely patent, with no technical defects.surgery (P  .0001). The absolute ABI increase in thesecases ranged from 0.05 to 0.56, with a mean of 0.26 
0.13. Twenty-two (88%) of 25 patients experienced a sig-
nificant (0.15) postprocedure ABI increase. In the re-
maining seven cases, we documented a significant increase
in the amplitude of forefoot tracings after the procedure.
The mean preprocedural amplitude was 1.8  1.6 mm
(range, 0-4 mm), and the mean postprocedural amplitude
was 7.5  3.3 mm (range, 3-13 mm; P  .004).
Hospital stay. The length of hospital stay ranged from
1 to 9 days (mean, 2.5  2.1 days; median, 2 days) in this
series.
Postoperative follow-up. The mean follow-up in
these patients was 5.2  3.7 months (range, 0-17 months;
median, 5 months).
Mortality, limb salvage, and patency. The overall
3-month survival and limb salvage rates were 100%. The
1- and 3-month femoropopliteal patency rates were 93%
and 62%, respectively, and for infrapopliteal arteries they
were 96% and 85%, respectively. The two-tailed P value was
not significant, at .1993, in the log-rank comparison of the
survival curve (95%) confidence intervals.
DISCUSSION
The data presented in this article confirm our belief that
nk stenosis subjected to balloon angioplasty. As shown,al truduplex-guided endovascular procedures can be safely and
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ment, but also in infrapopliteal arteries. These include
balloon angioplasties, subintimal dissections, thrombolysis,
and suction thrombectomies. The rate of immediate tech-
nical success for stenotic infrapopliteal lesions in this series
was 95%, and this is similar to the rates reported for stan-
dard fluoroscopically guided procedures using potentially
nephrotoxic contrast material: these rates varied from 85%
to 96%.4,6,16,17 Equally gratifying was to observe that our
early limb salvage rate was 100% at 3 months, whereas the
patency of the treated infrapopliteal segment was 85% at a
similar interval. It is interesting to note that the patency
results of infrapopliteal arteries were better than the ones
achieved in the femoropopliteal arterial segment. These
results may be skewed by the small number of cases in our
series andmay not be an actual reflection of the durability of
the balloon angioplasty in the infrapopliteal vessels.
It was encouraging to see that some of the complica-
tions associated with balloon angioplasty, such as emboli-
zation or thrombosis, could be accurately identified by
duplex examination and successfully corrected under du-
plex guidance. Although the incidence of acute thrombosis
of the outflow vessel may seem to be higher in this study
than the rates typically reported in the literature for fluoro-
scopically directed angioplasty, there are four possible ex-
planations. One relates to the potential limitation of unipla-
nar arteriography that could have missed a thrombus or
misread a thrombus as residual disease. Second, unfortu-
nately, we had two patients who did not receive adequate
amounts of heparin during the procedure and developed
intraoperative thrombosis. These patients required more
than time and a half the expected amounts of heparin to
achieve an activated clotting time longer than 250 seconds.
Both thrombolytic therapy and suction thrombectomy
were used in this series without the need to resort to
standard arteriographic techniques. Third, it is possible that
multiple balloon angioplasties performed concomitantly in
the same lower extremity may predispose to an increased
rate of local thrombosis. Fourth, regardless of the above-
mentioned possibilities, the observed increased rate of
thrombosis could be related to the imaging technique
proposed herein. We do not believe this to be the case, but
one has to keep in mind that any new technique may be
associated with an increased rate of complications, particu-
larly during the learning phase.
Except for the three cases that required catheterization
of the contralateral femoral artery, the cases in this series
were performed without fluoroscopy. This is potentially
safer for the patient, the surgeon, and all personnel in the
operating suite. We are convinced that without duplex
guidance, we would have performed many more contralat-
eral femoral punctures. The major disadvantage to this ap-
proach is that it places the contralateral asymptomatic limb
in danger of local and remote complications, including
pseudoaneurysms, thrombosis, and distal embolization.
This experience confirms our belief that balloon angio-
plasty of the infrapopliteal arteries is feasible under duplex
guidance alone. Excellent anatomic and hemodynamic re-sults may be expected from our approach regardless of the
extent of the stenotic lesion. However, one should be ready
to abandon this approach in favor of a more standard
technique whenever duplex visualization of the treated
segment is not acceptable, such as in cases of heavily calci-
fied arteries or in very obese patients in whom the target
arteries are deeper than 4 cm. It is important to emphasize
that duplex-guided procedures in the infrapopliteal arteries
should be attempted only in the presence of a knowledge-
able vascular technologist and an interventionist who is also
familiar with arterial duplex scanning of the lower extrem-
ity. Unquestionably, duplex-guided arterial interventions
are particularly beneficial for patients who are allergic to
contrast material and for those with chronic renal insuffi-
ciency. We strongly believe that the proposed technique
has great potential, and it should be attempted by other
groups to validate our results. It is anticipated that some of
these procedures will eventually be performed in the vascu-
lar laboratory or in an office practice setting.
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Dr John Blebea (Philadelphia, Pa). I want to commend you,
Dr Ascher, and your coauthors on your continuing excellent work
in extending the boundaries of vascular ultrasound and leading the
way in the use of arterial duplex for preoperative mapping and
percutaneous interventional procedures.
In this study, you have used duplex ultrasound to provide
imaging guidance in the performance of infrainguinal balloon
angioplasty and subintimal dissections in 52 procedures and 30
patients. You have also proposed duplex imaging as an alternative
to angiography in order to “avert the harmful effects of radiation
exposure and the risk of renal failure.” You further state that
“additional advantages include accurate selection of the proper
balloon size and confirmation of the adequacy of the technique by
hemodynamic and imaging parameters.” While you have shown
through this experience that ultrasound-directed balloon angio-
plasty can be done, you have yet to prove that it should be done or,
indeed, that any of the claimed benefits of this procedure actually
exist.
With this preamble in mind, I have several questions.
First, although extreme examples can be shown where stan-
dard radiation safety procedures have not been followed, do you
have any data to demonstrate that a significant radiation risk exists
to either patient or physician during the performance of infrain-
guinal balloon angioplasty rather than EVAR [endovascular aneu-
rysm repair]?
Second, I found that a combination of CO2 angiography and
intra-arterial gadolinium, both of which have minimal nephrotoxic
effects, can provide excellent imaging of the femoral, popliteal, and
tibial vessels. Do you have any experience with these techniques to
compare efficacy with duplex ultrasound?
Third, no data have been provided to indicate that contrast
angiography does not give adequate information to select the
appropriate size of balloon or evaluate satisfactory outcomes after
angioplasty. Indeed, intra-arterial pressure measurements provide
more valuable hemodynamic information than Doppler-derived
velocity or flow measurements. Can the authors provide substan-
tiation of these additional claimed benefits?
Finally, what about the associated costs for this procedure?
How long did it take to perform these procedures? And since they
were being done in the operating room, howmuchmore expensive
was it, taking into account that the operating room and the
anesthesia are associated with significant charges? Indeed, why do
these procedures in the operating room at all and not in the
vascular lab? We otherwise do percutaneous balloon angioplasties
without anesthesia or the operating room, and we do pseudoan-
eurysm injections in the vascular lab. In order to really save money
and truly expand the horizons of vascular surgeons in the vascular
laboratory, is not the next logical step to do these procedures in the
vascular lab? That would really be expanding the horizons of our
clinical practice. I look forward to your further work in this area.
Dr Ascher. John, thank you for your comments and ques-
tions. Let me tell you from the onset that our work is preliminary,
and based on the results achieved to the present, we are extremely
enthusiastic about this new approach.
Standard radiation safety precautions were devised to limit but
not eliminate the amount of potentially harmful radiation. Al-
though there are very few articles quantitating the amount of
radiation associated with lower extremity diagnostic arteriography,
there are none to our knowledge related to balloon angioplasty andthat repetitive exposure to radiation may indeed cause cataract,
dermatitis, etc, in the long run. Why take a risk when you don’t
have to?
Our experience with CO2 angiography and gadolinium has
not been satisfactory. There are several significant limitations with
these two techniques, including inadequate visualization and lack
of hemodynamic parameters.
It is very difficult to measure precisely the diameter of the
stenotic arterial segment, primarily because one can visualize only
the lumen and not the entire arterial wall when using arteriogra-
phy. We respectfully disagree with your statement that simple
arterial pressure measurements are more reliable than hemody-
namic parameters obtained with duplex scanning. How would you
suggest that one evaluate the significance of a residual infrapopli-
teal artery stenosis? Sticking needles proximally and distally to the
angioplasty site?
Some of your later questions are answered in detail in the
article. Yes, we do believe that our increased experience with these
procedures will lead us to attempt in selected cases to perform
balloon angioplasty with possible stenting in an office setting or in
the vascular laboratory.
Thank you, Dr Blebea.
Dr Mark Moritz (Morristown, NJ). Enrico, I congratulate
you on a body of work which has been changing my practice. I’ve
long been a believer in the capabilities of duplex ultrasound to
replace a lot of the things we’re used to doing with x-ray.
My questions are these that haven’t been answered yet.
We all know that duplex ultrasound is very operator depen-
dent. What you see is often a function not of what’s actually there,
but of what is shown to you. In the operating room, while you
operate with one hand and hold the probe with the other hand, it
must be extremely difficult. At this meeting, I’m sure you are
showing us your best pictures, but if you were to show us your
worst pictures, what would they be like? Do you have your ultra-
sound technologist scrubbed in with you, holding the probe on the
tissue with two hands, while you operate? I’d like to hear more
about that.
Dr Ascher. Well, I think it’s an excellent question, and I
should probably have mentioned this during my presentation. You
cannot do these procedures alone at this stage. Perhaps in the
future, when I learn more about it, I’ll be able to. But right now,
we have one dedicated vascular technologist who started this
process with us and went through the learning curve, and now
she’s very comfortable.
As amatter of fact, John Blebea askedme, how long does it take?
It takes me, for a stenosis, an average of 35minutes from skin to skin.
Of course, I leave the sheath there, and I send the patient to the
recovery roomwith the sheath, but the procedure itself takes, I’ll say,
about 35 minutes. I’m not rushing, because this person, Natalie
Marks, who is excellent in ultrasound, can actually guide me
through it. Sometimes I tell her, I probably can do this procedure
with my eyes closed because you’re telling me what to do. She’s
actually getting the image, the best image, all along the process.
But now we have started doing this with other technologists, and
for the stenosis they are learning very fast, actually.
Dr Moritz.My second question is this: in my OR [operating
room], we’re given the cast-off ultrasound units from the vascular
lab when they upgrade. And the units are really quite good. But my
question to you is, what constitutes the proper piece of equipment
to have in theOR for this procedure? Do you need a 5- to 10-MHz
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deeper probe? Do you need certain characteristics and capabilities
on that machine that might not be available everywhere? What
should we be looking for to bring that machine into the OR?
Dr Ascher. That’s another good question.
You need probes that can insonate deep planes, especially
around the popliteal artery above the knee. The popliteal artery
below the knee is much easier, but the segment is very hard—it’sthe Hunter’s canal area that is much harder. So you need an
abdominal probe. You need a superficial probe also for the SFA
proximally. So you need to have an array of probes. But I’m sure
you have that in your office right now.
Dr Moritz. Have you done this in the iliacs yet?
DrAscher. I have done it in the iliacs, but I don’t recommend
it at this point because it’s much more difficult to do in the iliacs
than the lower extremities.
